Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics. Join host Chris O'Brien as he and Dr. Tolentino, explore the traits of top problem solvers, the power of communication, and how silos and "bad apples" can undermine today's biotechs. Okay, let's start the podcast!

Episode metadata supplied by the publisher feed · Published Jul 15, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

0:00 39:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

#201 The myth of being prepared for every eventuality: how hoarding can make us less ready for emergencies

Oct 17, 2025 ·32m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 39 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on July 15, 2025.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!